Strategy

Assessing the threat from drug-resistant bacteria

Read more

Building multifunctional biologics to treat disease

Read more

Regulatory challenges for cell therapy manufacture

Read more

Artificial intelligence in drug development

Read more

Long-term strategies for immuno-oncology

Read more

A phenotypic share analysis

Read more

European biotech searches for growth capital

Read more

Case study - the merits of adaptive trial design

Read more

Seismic shift ahead for drug pricing

Read more

Drugs for orphan diseases are no longer rare

Read more